Nevakar
is a New Jersey-based biopharmaceutical company that develops and commercializes ophthalmic and injectable products for the healthcare sector... Read moreNevakar
is a New Jersey-based biopharmaceutical company that develops and commercializes ophthalmic and injectable products for the healthcare sector... Read more
News
Jul 04, 2023
Life Care News
Nevakar: Nevakar Injectables Announces FDA Approval of
May 02, 2022
Benzinga
Nevakar: Endo Acquires Six Development-Stage, Injectable Product Candidates For $35M
Mar 28, 2022
Seeking Alpha
Nevakar: Nevakar launches ready-to-use Ephedrine injection for low blood pressure
Mar 10, 2022
NJBIZ
Nevakar: Nevakar closes on $12M in convertible notes
May 26, 2021
NJBIZ
Nevakar: Nevakar launches ophthalmic subsidiary
Feb 02, 2021
FiercePharma
Nevakar: Tha inks $135M deal for EU rights to Nevakar's myopia eye drops
Jan 28, 2021
BioSpace
Nevakar: Nevakar and Tha Enter into Licensing Agreement for the Commercialization of NVK-002 (Atropine for the Treatment of the Progression of Myopia in Children) in Europe
Nov 12, 2020
ACN Newswire
Press Release: Nevakar : Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002
Oct 22, 2020
Micro Small Cap
Nevakar: Nevakar Announces FDA Approval for Ephedrine Sulfate Injection as Ready-to-Use Vials
Oct 20, 2020
BioSpace
Nevakar: Nevakar and Zhaoke Ophthalmology Enter into Licensing Agreement for NVK-002 (Atropine for the Treatment of the Progression of Myopia in Children)
Nevakar Competitors
1
2
3
4
5
6
7
8
9
10